NanoZolid®-formulated Docetaxel is Safe and Tolerable Showing Signs of Clinical Efficacy
October 04, 2021 13:30 ET
|
LIDDS AB
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that no further patients will be enrolled in its dose escalating Phase I study (NZ-DTX-001) with the primary objective to study safety of...
LIDDS patent covering the NanoZolid® production process granted in Russia and Australia
September 28, 2021 10:00 ET
|
LIDDS AB
UPPSALA, SWEDEN – LIDDS AB (publ) announces today that its most recent patent family on the NanoZolid® production process, and hence achieved pharmaceutical products, has been granted in Russia...
LIDDS Interim report January – June 2021
August 26, 2021 02:30 ET
|
LIDDS AB
JANUARY – JUNE 2021 Net sales amounted to MSEK 0.8 (0.0)Operating expenses amounted to MSEK -21.3 (-13.3)Profit/loss before and after tax amounted to MSEK -20.6 (-13.3)Earnings per share amounted...
LIDDS – subscription of warrants
July 06, 2021 08:00 ET
|
LIDDS AB
UPPSALA, SWEDEN – LIDDS AB (publ) The Annual General Meeting held on May 17, 2021, resolved to establish a warrants-based incentive programme 2021/2024 for the CEO and other key-persons in the...
LIDDS genomför en riktad nyemission av aktier och tillförs cirka 45 Mkr
June 02, 2021 16:00 ET
|
LIDDS AB
EJ FÖR DISTRIBUTION DIREKT ELLER INDIREKT, INOM ELLER TILL AUSTRALIEN, HONGKONG, JAPAN, KANADA, NYA ZEELAND, SCHWEIZ, SINGAPORE, SYDAFRIKA ELLER USA, ELLER I NÅGON ANNAN JURISDIKTION DÄR...
LIDDS carry out a directed share issue of and is provided with approximately MSEK 45
June 02, 2021 16:00 ET
|
LIDDS AB
NOT FOR DISTRIBUTION DIRECTLY OR INDIRECTLY, WITHIN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES, OR IN ANY OTHER JURISDICTION...
LIDDS Announces Appointment of Jenni Björnulfson as New Chief Financial Officer
June 01, 2021 02:45 ET
|
LIDDS AB
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that Jenni Björnulfson has been appointed new Chief Financial Officer (CFO) of LIDDS AB succeeding Anja Peters, who will leave LIDDS at the end of...
LIDDS new CEO will present at Redeye’s Growth Day and Aktiespararna’s Småbolagsdagarna
May 28, 2021 02:45 ET
|
LIDDS AB
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that LIDDS new CEO Nina Herne will hold her first presentation at Redeye’s Growth Day on June 2 at 13.50 pm CET. To follow the event,...
LIDDS avser att genomföra en riktad nyemission av aktier om cirka 45 Mkr
May 27, 2021 16:20 ET
|
LIDDS AB
EJ FÖR DISTRIBUTION DIREKT ELLER INDIREKT, INOM ELLER TILL AUSTRALIEN, HONGKONG, JAPAN, KANADA, NYA ZEELAND, SCHWEIZ, SINGAPORE, SYDAFRIKA ELLER USA, ELLER I NÅGON ANNAN JURISDIKTION DÄR...
LIDDS intends to carry out a directed share issue of approximately MSEK 45
May 27, 2021 16:20 ET
|
LIDDS AB
NOT FOR DISTRIBUTION DIRECTLY OR INDIRECTLY, WITHIN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES, OR IN ANY OTHER JURISDICTION...